# Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

> **NCT05122754** · PHASE4 · UNKNOWN · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 150 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** B/F/TAF
- **DRUG:** TDF-based triple ART regimen switching to B/F/TAF

## Key facts

- **NCT ID:** NCT05122754
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-08
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-04-28
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05122754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05122754, "Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05122754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*